Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amplimexon in previously treated multiple myeloma
NCT00327249Phase 2Completed
- Sponsor
- AmpliMed Corporation
- Start
- Oct 2005
- Primary completion
- Jul 2006
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of imexon in multiple myeloma (MM), sponsored by AmpliMed Corporation. Started Oct 2005; status: completed.
02
Drugs
imexon
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00327249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00327249.